Impact of CCL2 and CCR2 chemokine/receptor deficiencies on macrophage recruitment and continuous glucose monitoring in vivo

Biosensors and Bioelectronics

Volumn 86, Issue , 2016, Pages 262-269

  Klueh, Ulrike ^a   Czajkowski, Caroline ^a   Ludzinska, Izabela ^a   Qiao, Yi ^a   Frailey, Jackman ^a   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotaxis; Continuous glucose monitoring; Diabetes; Inflammation; Macrophage

Indexed keywords

BIOCHEMISTRY; MACROPHAGES; MAMMALS; MEDICAL PROBLEMS; PATHOLOGY; TISSUE;

CAUSAL RELATIONSHIPS; CHEMOTAXIS; CONTINUOUS GLUCOSE MONITORING; CONTINUOUS GLUCOSEMONITORING (CGM); GENETIC DEFICIENCIES; IMPLANTATION SITES; INFLAMMATION; SENSOR PERFORMANCE;

GLUCOSE;

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; GLUCOSE SENSOR; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; MURINE MODEL; NONHUMAN; TISSUE REACTION; AMBULATORY MONITORING; ANIMAL; BLOOD GLUCOSE MONITORING; C57BL MOUSE; CELL CULTURE; GLUCOSE BLOOD LEVEL; METABOLISM; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CELLS, CULTURED; CHEMOKINE CCL2; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MONITORING, AMBULATORY; RECEPTORS, CCR2; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84976905704     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2016.06.026     Document Type: Article

References (40)

1. Avula, M., Jones, D., Rao, A.N., McClain, D., McGill, L.D., Grainger, D.W., Solzbacher, F., Local release of masitinib alters in vivo implantable continuous glucose sensor performance. Biosens. Bioelectron. 77 (2016), 149–156.
2. Carfi, A., Smith, C.A., Smolak, P.J., McGrew, J., Wiley, D.C., Structure of a Soluble secreted Chemokine Inhibitor vCCI (p35) from Cowpox virus. Proc. Natl. Acad. Sci. USA 96:22 (1999), 12379–12383.
3. Carter, P.H., Brown, G.D., King, S.R., Voss, M.E., Tebben, A.J., Cherney, R.J., Mandlekar, S., Lo, Y.C., Yang, G., Miller, P.B., Scherle, P.A., Zhao, Q., Decicco, C.P., Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone. Bioorg. Med. Chem. Lett. 22:9 (2012), 3311–3316.
4. Castro, P.R., Marques, S.M., Viana, C.T., Campos, P.P., Ferreira, M.A., Barcelos, L.S., Andrade, S.P., Deletion of the chemokine receptor CCR2 attenuates foreign body reaction to implants in mice. Microvasc. Res. 95 (2014), 37–45.
5. Cherney, R.J., Mo, R., Meyer, D.T., Nelson, D.J., Lo, Y.C., Yang, G., Scherle, P.A., Mandlekar, S., Wasserman, Z.R., Jezak, H., Solomon, K.A., Tebben, A.J., Carter, P.H., Decicco, C.P., Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists. J. Med. Chem. 51:4 (2008), 721–724.
6. Deshmane, S.L., Kremlev, S., Amini, S., Sawaya, B.E., Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29:6 (2009), 313–326.
7. Fonseca, V.A., Grunberger, G., Anhalt, H., Bailey, T.S., Blevins, T., Garg, S.K., Handelsman, Y., Hirsch, I.B., Orzeck, E.A., Roberts, V.L., Tamborlane, W., Consensus Conference Writing, C., Continuous glucose monitoring: a consensus conference of the american association of clinical endocrinologists and american college of endocrinology. Endocr. Pract., 2016.
8. Foster, N.C., Miller, K.M., Tamborlane, W.V., Bergenstal, R.M., Beck, R.W., Network, T.D.E.C., Continuous glucose monitoring in patients with type 1 diabetes using insulin injections. Diabetes Care 39:6 (2016), e81–e82.
9. Ge, S., Shrestha, B., Paul, D., Keating, C., Cone, R., Guglielmotti, A., Pachter, J.S., The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis. J. Neuroinflammation, 9, 2012, 171.
10. Helton, K.L., Ratner, B.D., Wisniewski, N.A., Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and foreign body response-part II: examples and application. J. Diabetes Sci. Technol. 5:3 (2011), 647–656.
11. Helton, K.L., Ratner, B.D., Wisniewski, N.A., Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and the foreign body response-part I: theoretical framework. J. Diabetes Sci. Technol. 5:3 (2011), 632–646.
12. Khan, U.A., Hashimi, S.M., Bakr, M.M., Forwood, M.R., Morrison, N.A., CCL2 and CCR2 are essential for the formation of osteoclasts and foreign body giant cells. J. Cell. Biochem., 2015.
13. Klueh, U., Kaur, M., Montrose, D.C., Kreutzer, D.L., Inflammation and glucose sensors: use of dexamethasone to extend glucose sensor function and life span in vivo. J. Diabetes Sci. Technol. 1:4 (2007), 496–504.
14. Klueh, U., Kaur, M., Qiao, Y., Kreutzer, D.L., Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo. Biomaterials 31:16 (2010), 4540–4551.
15. Klueh, U., Liu, Z., Feldman, B., Kreutzer, D.L., Importance of interleukin 1/interleukin 1 receptor antagonist in short term glucose sensor function in vivo. Diabetes Sci. Technol. 4:5 (2010), 1073–1086.
16. Klueh, U., Antar, O., Qiao, Y., Kreutzer, D.L., Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo. J. Diabetes Sci. Technol. 7:6 (2013), 1538–1546.
17. Klueh, U., Antar, O., Qiao, Y., Kreutzer, D.L., Role of vascular networks in extending glucose sensor function: Impact of angiogenesis and lymphangiogenesis on continuous glucose monitoring in vivo. J. Biomed. Mater. Res. Part A, 2013.
18. Klueh, U., Qiao, Y., Frailey, J.T., Kreutzer, D.L., Impact of macrophage deficiency and depletion on continuous glucose monitoring in vivo. Biomaterials 35:6 (2014), 1789–1796.
19. Klueh, U., Frailey, J.T., Qiao, Y., Antar, O., Kreutzer, D.L., Cell based metabolic barriers to glucose diffusion: macrophages and continuous glucose monitoring. Biomaterials 35:10 (2014), 3145–3153.
20. Klueh, U., Qiao, Y., Czajkowski, C., Ludzinska, I., Antar, O., Kreutzer, D.L., Basement membrane-based glucose sensor coatings enhance continuous glucose monitoring in vivo. J. Diabetes Sci. Technol., 2015.
21. Klueh, U., Liu, Z., Feldman, B., Henning, T.P., Cho, B., Ouyang, T., Kreutzer, D., Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages. J. Diabetes Sci. Technol. 5:3 (2011), 583–595.
22. Klueh, U., Liu, Z., Cho, B., Ouyang, T., Feldman, B., Henning, T.P., Kaur, M., Kreutzer, D., Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. Diabetes Technol. Ther. 8:3 (2006), 402–412.
23. Kvist, P.H., Iburg, T., Bielecki, M., Gerstenberg, M., Buch-Rasmussen, T., Hasselager, E., Jensen, H.E., Biocompatibility of electrochemical glucose sensors implanted in the subcutis of pigs. Diabetes Technol. Ther. 8:4 (2006), 463–475.
24. Kyriakides, T.R., Foster, M.J., Keeney, G.E., Tsai, A., Giachelli, C.M., Clark-Lewis, I., Rollins, B.J., Bornstein, P., The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am. J. Pathol. 165:6 (2004), 2157–2166.
25. Luu, T.U., Gott, S.C., Woo, B.W., Rao, M.P., Liu, W.F., Micro- and nanopatterned topographical cues for regulating macrophage cell shape and phenotype. ACS Appl. Mater. Interfaces 7:51 (2015), 28665–28672.
26. Miller, K., Foster, N., Tamborlane, W., Bergenstal, R., Beck, R., Continuous glucose monitoring in T1D patients using injections of insulin: a report from the T1D Exchange clinic registry. Diabetes Technol. Ther., 18, 2016, 069 A-27 Abstr.
27. Moore, L.B., Sawyer, A.J., Charokopos, A., Skokos, E.A., Kyriakides, T.R., Loss of monocyte chemoattractant protein-1 alters macrophage polarization and reduces NFkappaB activation in the foreign body response. Acta Biomater. 11 (2015), 37–47.
28. Norton, L.W., Koschwanez, H.E., Wisniewski, N.A., Klitzman, B., Reichert, W.M., Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J. Biomed. Mater. Res. Part A 81:4 (2007), 858–869.
29. Novak, M.T., Reichert, W.M., Modeling the physiological factors affecting glucose sensor function in vivo. J. Diabetes Sci. Technol. 9:5 (2015), 993–998.
30. Novak, M.T., Yuan, F., Reichert, W.M., Predicting glucose sensor behavior in blood using transport modeling: relative impacts of protein biofouling and cellular metabolic effects. J. Diabetes Sci. Technol. 7:6 (2013), 1547–1560.
31. Novak, M.T., Yuan, F., Reichert, W.M., Macrophage embedded fibrin gels: an in vitro platform for assessing inflammation effects on implantable glucose sensors. Biomaterials 35:36 (2014), 9563–9572.
32. Obermaier, K., Schmelzeisen-Redeker, G., Schoemaker, M., Klotzer, H.M., Kirchsteiger, H., Eikmeier, H., del Re, L., Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment. J. Diabetes Sci. Technol. 7:4 (2013), 824–832.
33. Semple, B.D., Frugier, T., Morganti-Kossmann, M.C., CCL2 modulates cytokine production in cultured mouse astrocytes. J. Neuroinflammation, 7, 2010, 67.
34. Semple, B.D., Kossmann, T., Morganti-Kossmann, M.C., Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. 30:3 (2010), 459–473.
35. Semple, B.D., Bye, N., Rancan, M., Ziebell, J.M., Morganti-Kossmann, M.C., Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J. Cereb. 30:4 (2010), 769–782.
36. Skokos, E.A., Charokopos, A., Khan, K., Wanjala, J., Kyriakides, T.R., Lack of TNF-alpha-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages. Am. J. Pathol. 178:5 (2011), 2311–2321.
37. Updike, S.J., Shults, M., Ekman, B., Implanting the glucose enzyme electrode: problems, progress, and alternative solutions. Diabetes Care 5:3 (1982), 207–212.
38. White, G.E., Iqbal, A.J., Greaves, D.R., CC chemokine receptors and chronic inflammation – therapeutic opportunities and pharmacological challenges. Pharmacol. Rev. 65:1 (2013), 47–89.
39. You, H., Altier, C., Zamponi, G.W., CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels. Mol. Pharmacol. 77:2 (2010), 211–217.
40. Zschornack, E., Schmid, C., Pleus, S., Link, M., Klotzer, H.M., Obermaier, K., Schoemaker, M., Strasser, M., Frisch, G., Schmelzeisen-Redeker, G., Haug, C., Freckmann, G., Evaluation of the performance of a novel system for continuous glucose monitoring. J. Diabetes Sci. Technol. 7:4 (2013), 815–823.